Literature DB >> 1385718

Epidemiology of vertebral osteoporosis.

J A Kanis1, E V McCloskey.   

Abstract

Whereas the extent, morbidity and costs of hip and Colles' fracture are well recognised from epidemiological studies, those arising from vertebral fracture are less secure. Reasons relate to the uncertain definition of vertebral fracture and its variable clinical expression, and hence its incidence is not known. Utilising radiological criteria 50% or more of vertebral fractures may be asymptomatic. In the remainder morbidity is significant, particularly in the presence of multiple vertebral fractures. Although the true incidence of vertebral fracture is unknown there is evidence that it increases exponentially with age in much the same way as for hip fracture. Between the ages of 60 and 90 years the apparent incidence rises approximately 20-fold in women compared to a 50-fold increase in risk of hip fracture. The incidence of vertebral osteoporosis is two-fold lower in men than in women at all ages, comparable to the pattern observed with other osteoporotic fractures. However, there is a relatively high incidence of vertebral fracture in men during middle adult-life (probably due to trauma), so that the prevalence of vertebral fracture in the male community is not two-fold less than in women.

Entities:  

Mesh:

Year:  1992        PMID: 1385718     DOI: 10.1016/8756-3282(92)90189-4

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  32 in total

Review 1.  The burden of osteoporosis.

Authors:  J A Kanis; O Johnell
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

2.  The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria: prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis (A-TOP) Research Group.

Authors:  Masataka Shiraki; Tatsuhiko Kuroda; Toshitaka Nakamura; Masao Fukunaga; Takayuki Hosoi; Hajime Orimo; Kuniyoshi Makino
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

3.  Influence of maternal genetic and lifestyle factors on bone mineral density in adolescent daughters: a cohort study in 387 Japanese daughter-mother pairs.

Authors:  Tatsuhiko Kuroda; Yoshiko Onoe; Yuko Miyabara; Remi Yoshikata; Seiya Orito; Ken Ishitani; Hiroya Okano; Hiroaki Ohta
Journal:  J Bone Miner Metab       Date:  2009-02-27       Impact factor: 2.626

4.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group.

Authors:  J A Kanis
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507

5.  [Burden of illness in vertebral deformities. EVOS group in Germany].

Authors:  C Matthis; H Raspe
Journal:  Med Klin (Munich)       Date:  1998-03-15

6.  Direct costs of osteoporosis for New Zealand women.

Authors:  A Lane
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

7.  Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.

Authors: 
Journal:  CMAJ       Date:  1996-10-15       Impact factor: 8.262

8.  Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study.

Authors:  Masataka Shiraki; Akira Itabashi
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

9.  The hospital cost of vertebral fractures in the EU: estimates using national datasets.

Authors:  Henrik W Finnern; David P Sykes
Journal:  Osteoporos Int       Date:  2003-04-30       Impact factor: 4.507

Review 10.  Postmenopausal hormone therapy: impact on menopause-related symptoms, chronic disease and quality of life.

Authors:  Marius Jan van der Mooren; Peter Kenemans
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.